Background: Premature birth results in a delayed and abnormal qualitative pattern of gut colonization. This abnormal pattern is thought to affect intestinal development and contribute to a higher risk of gastrointestinal infectious diseases such as neonatal necrotizing enterocolitis (NEC). In particular, bifidobacteria are thought to play a major role. We therefore studied bifidobacterial colonization in preterm infants during the first month of life.
Patients And Methods: Fecal samples were prospectively analyzed in 52 infants born at a gestational age ranging from 30 to 35 weeks fed with a preterm formula alone and, in 18, with their mother's milk. Fecal samples were collected twice per week during the hospital stay. Bifidobacterial colonization was analyzed with culture and a molecular method.
Results: Bifidobacterial colonization occurred in 18 infants at a median age of 11 days, always greater than the corrected mean gestational age of 35.4 weeks (SD, 0.9) and greater than 34 weeks for 16 of 18. Colonization by bifidobacteria was affected by neither birthweight nor mode of delivery nor antibiotics given to the mother or infant. In contrast, birth gestational age had a significant impact on colonization by bifidobacteria (P < 0.05), which always occurred in children born at a birth gestational age greater than 32.9 weeks (P < 0.05).
Conclusions: Birth gestational age seems to act as a major determinant of bifidobacterial colonization in the premature infant, suggesting the role of gut maturation, a finding that should probably be taken into account in manipulations of the gut flora aimed at reducing NEC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MPG.0b013e3180406b20 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Selective human milk oligosaccharide utilization by members of the taxon.
Appl Environ Microbiol
October 2024
APC Microbiome Ireland, University College Cork, Cork, Ireland.
Article Synopsis
- Human milk oligosaccharides (HMOs) are not digested by infants but help promote beneficial bacteria like bifidobacteria in their gut.
- The study explored how 23 newly isolated bifidobacterial strains grow on specific HMOs, identifying key genes connected to their metabolism, especially through a strain named MM0196.
- The research enhances our understanding of HMOs' role in gut health for infants, suggesting potential benefits for probiotic applications and improved infant nutrition, possibly extending to adults.
Molecular cross-talk among human intestinal bifidobacteria as explored by a human gut model.
Front Microbiol
September 2024
Laboratory of Probiogenomics, Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy.
Bifidobacteria are well known as common and abundant colonizers of the human gut and are able to exert multiple beneficial effects on their host, although the cooperative and competitive relationships that may occur among bifidobacterial strains are still poorly investigated. Therefore, to dissect possible molecular interactions among bifidobacterial species that typically colonize the human gut, three previously identified bifidobacterial prototypes, i.e.
View Article and Find Full Text PDFExploring the Potential Probiotic Properties of Bifidobacterium breve DSM 32583-A Novel Strain Isolated from Human Milk.
Probiotics Antimicrob Proteins
September 2024
Chair of intestinal Microbiome, ZIEL - Institute for Food & Health, Technical University of Munich, Weihenstephaner Berg 3, 85354, Freising, Germany.
Human milk is the best nutrition for infants, providing optimal support for the developing immune system and gut microbiota. Hence, it has been used as source for probiotic strain isolation, including members of the genus Bifidobacterium, in an effort to provide beneficial effects to infants who cannot be exclusively breastfed. However, not all supplemented bifidobacteria can effectively colonise the infant gut, nor confer health benefits to the individual infant host; therefore, new isolates are needed to develop a range of dietary products for this specific age group.
View Article and Find Full Text PDFFrom raw milk cheese to the gut: investigating the colonization strategies of .
Appl Environ Microbiol
September 2024
Laboratory of Probiogenomics, Department of Chemistry, Life Sciences, and Environmental Sustainability, University of Parma, Parma, Italy.
The microbial ecology of raw milk cheeses is determined by bacteria originating from milk and milk-producing animals. Recently, it has been shown that members of the species may become transmitted along the Parmigiano Reggiano cheese production chain and ultimately may colonize the consumer intestine. However, there is a lack of knowledge regarding the molecular mechanisms that mediate the interaction between and the human gut.
View Article and Find Full Text PDFIntegrative genomic reconstruction of carbohydrate utilization networks in bifidobacteria: global trends, local variability, and dietary adaptation.
bioRxiv
July 2024
Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Rd, La Jolla, CA 92037, USA.
Article Synopsis
- Bifidobacteria are important early colonizers of the gut and offer various health benefits, but individual responses to probiotics can differ based on factors like strain type and diet.
- A study reconstructed 66 pathways related to carbohydrate utilization in bifidobacteria, revealing significant variability in their glycan metabolism capabilities at both species and strain levels.
- This research enhances understanding of bifidobacterial metabolism and lays the groundwork for developing targeted probiotic and synbiotic formulations that optimize health benefits.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!